Chemical Program >
Advisories to the Public >
Special Surveillance List of
Chemicals, Products, Materials and Equipment Used in the Clandestine
Production of Controlled Substances or Listed Chemicals
Special Surveillance List
of Chemicals, Products, Materials and Equipment Used in the Clandestine
Production of Controlled Substances or Listed Chemicals
Preface
The Comprehensive Methamphetamine Control Act of
1996 makes it illegal for any person to distribute a "laboratory
supply," which is defined in the final rule as a "listed
chemical or any chemical substance, or item on a special surveillance
list published by the Attorney General, which contains chemicals,
products, materials or equipment used in the manufacture of controlled
substances and listed chemicals." This final notice contains the
list of "laboratory supplies" which constitute the Special
Surveillance List. The term "distribution" includes the
exportation of a laboratory supply.
The Special Surveillance List focuses on
laboratory supplies used in domestic production of controlled substances
and listed chemicals. The Drug Enforcement Administration (DEA) chose to
limit the number of chemicals, products, materials and equipment on the
list to those most frequently used in the clandestine production of
controlled substances or listed chemicals.
Note that when reading Page 25912
of the Federal Register Notice, the following correction applies: Under
the heading Small Business Impact and Regulatory Flexibility
Concerns, a portion of the text was inadvertently omitted,
which could result in confusion regarding the civil penalty provisions.
The paragraph beginning "The notice serves
two purposes . . . " should read as follows:
The notice serves two purposes. First, it
informs individuals and firms of the potential use of the items on the
list for the production of listed chemicals and illicit drugs. Second,
it advises individuals and firms that civil penalties may be imposed on
them if they distribute a laboratory supply to a person who uses, or
attempts to use, that laboratory supply to manufacture a controlled
substance or a listed chemical, if the distribution is made with
"reckless disregard" for the illegal uses to which the
laboratory supply could be put. There is a rebuttable presumption of
"reckless disregard" if the distribution is made anytime after
the two week period following the receipt of written notification by the
Attorney General that the customer has used, attempted to use, or
distributed the laboratory supply further for the unlawful production of
a controlled substance or listed chemical.
This Special Surveillance List may be revised as
appropriate. Notice of proposed changes will be published in the Federal
Register as they occur.
In addition to being available on the DEA
homepage, the current surveillance list will be available on the U.S.
Government Printing Office web site: http://www.access, gpo.gov/nara/cfr/index.html,
which provides access to the Federal Register.
Click here for the Federal
Register Notice.
[Federal Register: May 13, 1999 (Volume 64, Number
92)]
[Notices]
[Page 25910-25912]
From the Federal Register Online via GPO Access [http://www.access.gpo.gov/nara/cfr/index.html]
[DOCID:fr13my99-96]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[DEA-172N]
Special Surveillance List of Chemicals, Products,
Materials and Equipment Used in the Clandestine Production of Controlled
Substances or Listed Chemicals
AGENCY: Drug Enforcement Administration (DEA),
Justice.
ACTION: Final notice.
SUMMARY: On October 3, 1996, the Comprehensive
Methamphetamine Control Act of 1996 (MCA) was signed into law. The MCA
makes it unlawful for any person to distribute a laboratory supply to a
person who uses, or attempts to use, that laboratory supply to
manufacture a controlled substance or a listed chemical, with reckless
disregard for the illegal uses to which such laboratory supply will be
put. Individuals who violate this provision are subject to a civil
penalty of not more than $25,000; businesses which violate this
provision are subject to a civil penalty of not more than $250,000. The
term "laboratory supply" is defined as "a listed chemical or
any chemical, substance, or item on a special surveillance list
published by the Attorney General, which contains chemicals, products,
materials, or equipment used in the manufacture of controlled substances
and listed chemicals.'' This final notice contains the list of "laboratory supplies'' which constitutes the Special Surveillance List
that was required to be published by the Attorney General pursuant to
Title 21, United States Code, Section 42(a).
EFFECTIVE DATE: May 13, 1999.
FOR FURTHER INFORMATION CONTACT: Frank Sapienza,
Chief, Drug and Chemical Evaluation Section, Office of Diversion
Control, Drug Enforcement Administration, Washington, D.C. 20537,
Telephone (202) 307-7183.
SUPPLEMENTARY INFORMATION: On October 3, 1996, the
Comprehensive Methamphetamine Control Act of 1996 (MCA) was signed into
law. The MCA broadens controls on listed chemicals used in the
production of methamphetamine and other controlled substances, increases
penalties for the trafficking and manufacturing of methamphetamine and
listed chemicals, and expands regulatory controls to include the
distribution of lawfully marketed drug products which contain
the listed chemicals ephedrine, pseudoephedrine and phenylpropanolamine.
The MCA also provides for the publication of a Special
Surveillance List by the Attorney General. 21 U.S.C. 842(a). The Special
Surveillance List identifies laboratory supplies which are used in the
manufacture of controlled substances or listed chemicals. The MCA
defines "laboratory supply'' as "a listed chemical or any chemical,
substance, or item on a special surveillance list published by the
Attorney General which contains chemicals, products, materials, or
equipment used in the manufacture of controlled substances and listed
chemicals.'' 21 U.S.C. 842(a).
The Deputy Administrator of the DEA, in a December
1, 1998, Federal Register notice (63 FR 66201), published a proposed
Special Surveillance List. The notice provided an opportunity for all
interested parties to submit their comments and objections in writing on
the proposed Special Surveillance List until December 31, 1998, DEA
received one comment regarding the proposal. The comment was a joint
response from the Agricultural Retailers Association (ARA) and The
Fertilizer Institute (TFI). Both organizations fully supported the DEA's
implementation of the Methamphetamine Control Act of 1996 and
specifically the publication of the "Special Surveillance List'' of
laboratory supplies used in methamphetamine production. The ARA/TFI,however,
asked if its members would be subject to the $250,000 civil penalty
provisions of the MCA for thefts of anhydrous ammonia, a Special
Surveillance List chemical, from portable tanks stored on their
properties. In response to the ARA/TFI question, the civil penalty
provision of the MCA applies to a "distribution'' or "sale'' of a
laboratory supply by a business or firm to a customer for the unlawful
production of controlled substances or listed chemicals. A theft by
definition is not a distribution or a sale and thus individuals would
not be subject to the civil penalty provisions of the MCA for thefts of
a laboratory supply.
The MCA provides for a civil penalty of not more
than $250,000 for the distribution by a business of a laboratory supply
to a person who uses, or attempts to use, that laboratory supply to
manufacture a controlled substance or a listed chemical, if that
distribution was made with "reckless disregard'' for the illegal uses
to which such a laboratory supply would be put. 21 U.S.C. 842(a)(11),
842(c)(2)(C). Individuals who violate 21 U.S.C. 84(a)(11) are subject to
a civil penalty of not more than $25,000. 21 U.S.C 842(c)(1)(A). For
purposes of this provision, the term "distribution'' includes the
exportation of a laboratory supply.
The MCA further states that, for purposes of 21
U.S.C. 842(a)(11), there is a "rebuttable presumption of reckless
disregard at trial if the Attorney General notifies a firm in writing
that a laboratory supply sold by the firm, or any other person or firm,
has been used by a customer of the notified firm, or distributed further
by that customer, for the unlawful production of controlled substances
or listed chemicals a firm distributes and 2 weeks or more after the
notification the notified firm distributes a laboratory supply to the
customer.''
The CSA contains other sections relating to the
illegal manufacture of controlled substances. Section 841(d)(2) of Title
21 provides that any person who knowingly or intentionally distributes a
listed chemical knowing, or having reasonable cause to believe, that it
will be used in the illegal manufacture of a controlled substance, is
subject to criminal prosecution. Section 843(a)(7) of Title 21 provides
that any person who knowingly or intentionally distributes any chemical,
product, equipment or material which may be used to manufacture a
controlled substance or listed chemical, knowing, intending, or having
reasonable cause to believe, that it will be used to mauufacture a
controlled substance or listed chemical, is subject to criminal
prosecution.
In developing the Special Surveillance List, the
DEA consulted with both DEA and State/Local law enforcement and forensic
laboratory authorities. The DEA examined clandestine laboratory seizure
reports for information regarding: (1) Illicit drug production methods;
(2) chemicals actually used in clandestine production of controlled
substances and listed chemicals; and (3) the role and importance of
chemicals used in the syntheses. In addition, the DEA considered the
legitimate uses and market for these chemicals.
The Special Surveillance List focuses on chemicals
used in the domestic production of controlled substances and listed
chemicals. Therefore the list includes those chemicals used not only in
the production of methamphetamine, but also of other
controlled substances such as PCP, LSD, methcathinone and amphetamine.
The list does not focus on chemicals used in the production of heroin or
cocaine since these drugs are seldom produced domestically. However, the
Special
Surveillance List includes all listed chemicals as
specified in 21 CFR 1310.02 (a) or (b). The phrase "all listed
chemicals'' includes all chemical mixtures and all over-the-counter
(OTC) pharmaceutical products and dietary supplements which contain a
listed chemical, regardless of their dosage form or packaging and
regardless of whether the chemical mixture, drug product or dietary
supplement is exempt from regulatory controls.
The following is the Special Surveillance List for
laboratory supplies used in the manufacture of controlled substances and
listed chemicals:
Special Surveillance List Published Pursuant to
Title 21, United States Code, Section 842(a)(11)
Chemicals
All listed chemicals as specified in 21 CFR
1310.02 (a) or (b). This includes all chemical mixtures and all
over-the-counter (OTC) products and dietary supplements which contain a
listed chemical, regardless of their dosage form or packaging and
regardless of whether the chemical mixture, drug product or dietary
supplement is exempt from regulatory controls.
- Ammonia Gas
- Ammonium Formate
- Bromobenzene
- 1,1-Carbonyldiimidazole
- Cyclohexanone
- 1,1-Dichloro-1-fluoroethane (e.g. Freon 141B)
- Diethylamine and its salts
- 2,5-Dimethoxyphenethylamine and its salts
- Formamide
- Formic Acid
- Hypophosphorous Acid
- Lithium Metal
- Lithium Aluminum Hydride
- Magnesium Metal (Turnings)
- Mercuric Chloride
- N-Methylformamide
- Organomagnesium Halides (Grignard Reagents) (e.g. ethylmagnesium bromide
and phenylmagnesium bromide)
- Phenylethanolamine and its salts
- Phosphorus Pentachloride
- Potassium Dichromate
- Pyridine and its salts
- Red Phosphorus
- Sodium Dichromate
- Sodium Metal
- Thionyl Chloride
- ortho-Toluidine
- Trichloromonofluoromethane (e.g. Freon-11, Carrene-2)
- Trichlorotrifluoroethane (e.g. Freon 113)
Equipment
- Hydrogenators
- Tableting Machines
- Encapsulating Machines
- 22 Liter Heating Mantels
Individuals and firms which distribute listed
chemicals and chemicals, products, materials, or equipment on the above
list, are hereby officially notified that these materials may be used in
the illicit production of certain controlled substances or listed
chemicals.
The Attorney General has delegated authority under
the CSA and all subsequent amendments to the CSA to
[[Page 25912]]
the Administrator of the DEA pursuant to 28 CFR
0.100. The Administrator, in turn, has redelegated this authority to the
Deputy Administrator pursuant to 28 CFR 0.104.
This surveillance list may be revised as
appropriate. Notice of proposed changes will be published as they occur.
While publication in the Federal Register satisfies the notification
requirements for the Special Surveillance List, DEA is attempting to
disseminate the list as widely as possible. Therefore, copies of the
list will be sent to appropriate industry associations and trade
journals, and to the extent practical, to individual manufacturers and
distributors of "laboratory supplies."' In addition, a current
surveillance list will be available on the DEA homepage at
http://www.usdoj.gov/dea/.
Small Business Impact and Regulatory Flexibility
Concerns
The Special Surveillance List applies to all
individuals and firms which distribute the listed chemicals and
laboratory supplies (chemicals, products, materials, or equipment) on
the list. The notice does not impose any record-keeping or reporting
requirements for any of the laboratory supplies which are not listed
chemicals. Thus the surveillance list will have a negligible impact on
affected parties. The notice serves two
purposes. First, it informs individuals and firms of the potential use
of the items on the list for the production of listed chemicals and
illicit drugs. Second, it advises individuals and firms that civil
penalties may be imposed on them if they distribute a laboratory supply
to a person anytime after the two week period following receipt of
written notification by the Attorney General that the person has used,
attempted to use, or distributed the laboratory supply further for the
unlawful production of controlled substances or listed chemicals.
DEA chose to limit the number of chemicals,
products, materials, and equipment on the Special Surveillance List to
those most frequently used in the clandestine production of controlled
substances or listed chemicals. Limiting the number of such items on the
list minimizes the impact on wholesalers and retailers of the chemicals.
The Deputy Administrator hereby certifies that
this notice has been drafted in a manner consistent with the principles
of the Regulatory Flexibility Act (5 U.S.C. 601 et seq.). This notice
will provide an increased level of law enforcement control to prevent
the diversion of laboratory supplies used for the production of listed
chemicals and controlled substances. It will not however impose any new
regulatory burden on the public. This notice fulfills the requirement
imposed by Section 205 of the Methamphetamine Control Act (MCA) of 1996
that the Attorney General shall publish a special surveillance list
which contains chemicals, products, materials, or equipment used in the
manufacture of listed chemicals and controlled substances. A copy of
this notice has been provided to the Chief Counsel for Advocacy at the
Small Business Administration.
This notice has been drafted and reviewed in
accordance with Executive Order 12866. This notice has not been
determined to be a significant action. Therefore, this notice has not
been reviewed and approved by the Office of Management and Budget.
This action has been analyzed in accordance with
the principles and criteria in Executive Order 12612, and it has been
determined that this notice does not have sufficient federalism
implications to warrant the preparation of a Federalism Assessment.
This notice will not result in the expenditure by
State, local, and tribal governments, in the aggregate, or by the
private sector, of $100,000,000 or more in any one year, and will not
significantly or uniquely affect small governments. Therefore, no
actions were deemed necessary under the provisions of the Unfunded
Mandates Reform Act of 1995.
This notice is not a major rule as defined by
Section 804 of the Small Business Regulatory Enforcement Fairness Act of
1996. This notice will not result in an annual effect on the economy of
$100,000,000 or more; a major increase in costs or prices; or
significant adverse effects on competition, employment, investment,
productivity, innovation, or on the ability of United States-based
companies to compete with foreign-based companies in domestic and export
markets.
Dated: May 3, 1999.
Donnie R. Marshall,
Deputy Administrator.
[FR Doc. 99-12037 Filed
5-12-99; 8:45 am]
BILLING CODE 4410-09-M
|